Treatment of chronic hepatitis C patients with the NS3/4A protease inhibitor danoprevir (ITMN-191/RG7227) leads to robust reductions in viral RNA: a phase 1b multiple ascending dose study.
Data and Resources
Additional Info
| Field | Value |
|---|---|
| Source | ISSN: 0168-8278 |
| Author | Forestier, Nicole, Larrey, Dominique, Guyader, Dominique, Marcellin, Patrick, Rouzier, Régine, Patat, Alain, Smith, Patrick, Bradford, Williamson, Porter, Steven, Blatt, Lawrence, Seiwert, Scott D., Zeuzem, Stefan |
| Maintainer | CCSD |
| Last Updated | October 30, 2026, 21:44 (UTC) |
| Created | October 30, 2026, 21:44 (UTC) |
| Identifier | hal-00742163 |
| Language | en |
| contributor | Johann Wolfgang Goethe University Medical Center ; Johann Wolfgang Goethe University Medical Center |
| creator | Forestier, Nicole |
| date | 2011-06-30T00:00:00 |
| harvest_object_id | db663a3c-0a90-4658-be65-fb9c31e8cff2 |
| harvest_source_id | 3374d638-d20b-4672-ba96-a23232d55657 |
| harvest_source_title | test moissonnage SELUNE |
| metadata_modified | 2026-08-11T00:00:00 |
| relation | info:eu-repo/semantics/altIdentifier/doi/10.1016/j.jhep.2010.11.001 |
| set_spec | type:ART |